Selective decrease in complement C2 hemolytic activity is a sensitive marker for cryoglobulinemia and active disease in hepatitis C patients
- 18 January 2021
- journal article
- research article
- Published by Elsevier BV in Digestive and Liver Disease
- Vol. 53 (7), 860-865
- https://doi.org/10.1016/j.dld.2020.12.124
Abstract
No abstract availableKeywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
This publication has 29 references indexed in Scilit:
- Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)Viruses, 2012
- Rheumatoid Factor, Complement, and Mixed CryoglobulinemiaJournal of Immunology Research, 2012
- Hepatitis C Virus Proteins Inhibit C3 Complement ProductionJournal of Virology, 2012
- Hepatitis C Virus Infection and Mixed CryoglobulinemiaJournal of Immunology Research, 2012
- Transcriptional Repression of C4 Complement by Hepatitis C Virus ProteinsJournal of Virology, 2011
- Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular DamageThe Journal of Immunology, 2009
- Complement Component C2, Inhibiting a Latent Serine Protease in the Classical Pathway of Complement ActivationBiochemistry, 2009
- The structure of C2b, a fragment of complement component C2 produced during C3 convertase formationActa crystallographica. Section D, Structural biology, 2009
- Structure of Complement Component C2a: Implications for Convertase Formation and Substrate BindingStructure, 2006
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CJournal of Hepatology, 2003